Employment of a Resazurin Viability-Based Assay for Minimum Inhibitory and Bactericidal Concentration Determination
Pharmaceuticals · 19.03.2026 · 19 (3) · 505
DOI: 10.3390/ph19030505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.03.2026. Verfasst von Lorena G Calvo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Parasitology, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The increasing prevalence of antimicrobial-resistant bacteria highlights the need for improved methodologies to evaluate antimicrobial activity beyond conventional minimum inhibitory concentration testing. While resazurin-based assays are widely used for minimum inhibitory concentration determination due to their simplicity and sensitivity, minimum bactericidal concentration assessment still relies on labor-intensive colony-forming unit counting. The objective of this study was to develop and validate a resazurin-based microwell assay capable of determining both the minimum inhibitory concentration and the minimum bactericidal concentration without routine plate counting, thereby simplifying bactericidal evaluation.
Methods
A two-step resazurin-based fluorescence assay was designed and performed in microplates. After determining the minimum inhibitory concentration using resazurin as a metabolic indicator, well-showing inhibited bacterial growths were subjected to a regrowth phase by transferring aliquots into fresh antimicrobial-free medium containing resazurin. This additional step allowed discrimination between reversible metabolic inhibition and irreversible bacterial death. The method was evaluated using ciprofloxacin and chloramphenicol against four bacterial species: Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Minimum bactericidal concentration values obtained using this assay were compared with those obtained through conventional colony counting on agar plates.
Results
Minimum bactericidal concentration values obtained using the two-step fluorescence assay were fully concordant with the conventional colony-forming unit counting method for all tested antibiotics and bacterial species.
Conclusions
The proposed two-step resazurin-based microwell assay represents a rapid, reliable, and less labor-intensive alternative for the determination of both the minimum inhibitory concentration and the minimum bactericidal concentration, with potential applications in clinical and industrial microbiology laboratories.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Parasitology, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
- Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36213 Vigo, Spain.
- Agribiotechnology and Precision Breeding for Food Security National Laboratory, Institute of Genetics and Biotechnology, Hungarian University of Agriculture and Life Sciences (MATE), 2100 Gödöllő, Hungary.
ORCID-Profile: Lorena G Calvo, Rosa-Antía Villarino, Sandra Sánchez, Trinidad de Miguel
Zitieren
APA
Calvo, L. G., Corral-Orbe, S., Villarino, R. A., Sánchez, S., & de Miguel, T. (2026). Employment of a Resazurin Viability-Based Assay for Minimum Inhibitory and Bactericidal Concentration Determination. Pharmaceuticals, 19(3), 505. https://doi.org/10.3390/ph19030505
Vancouver
Calvo LG, Corral-Orbe S, Villarino RA, Sánchez S, de Miguel T. Employment of a Resazurin Viability-Based Assay for Minimum Inhibitory and Bactericidal Concentration Determination. Pharmaceuticals. 2026;19(3):505. doi:10.3390/ph19030505
BibTeX
@article{Calvo2026,
author = {Calvo, Lorena G and Corral-Orbe, Stephanya and Villarino, Rosa-Antía and Sánchez, Sandra and de Miguel, Trinidad},
title = {Employment of a Resazurin Viability-Based Assay for Minimum Inhibitory and Bactericidal Concentration Determination},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {3},
pages = {505},
doi = {10.3390/ph19030505}
}
EUVIMED